Ständer, Sonja

Visual Analogue Scale: Evaluation of the Instrument for the Assess­ment of Pruritus

Reich, A., Heisig, M., Phan, N., Taneda, K., Takamori, K., Takeuchi, S., Furue, M., Blome, C., Augustin, M., Ständer, S., et al. (2012) · Acta Dermato Venereologica

Dermatology and Skin DiseasesContact Dermatitis and Allergies

Cited by 504

Correlation of IL-31 serum levels with severity of atopic dermatitis

Raap, U., Wichmann, K., Bruder, M., Ständer, S., Wedi, B., Kapp, A., & Werfel, T. (2008) · Journal of Allergy and Clinical Immunology

Dermatology and Skin DiseasesAsthma and respiratory diseases

Cited by 299

Trial of Nemolizumab in Moderate-to-Severe Prurigo Nodularis

Ständer, S., Yosipovitch, G., Legat, F. J., Lacour, J.-P., Paul, C., Narbutt, J., Bieber, T., Misery, L., Wollenberg, A., Reich, A., et al. (2020) · New England Journal of Medicine

Dermatology and Skin DiseasesPsoriasis: Treatment and Pathogenesis

Cited by 281

Unmet medical needs in chronic, non-communicable inflammatory skin diseases

Ujiie, H., Rosmarin, D., Schön, M. P., Ständer, S., Boch, K., Metz, M., Maurer, M., Thaci, D., Schmidt, E., Cole, C., et al. (2022) · Frontiers in Medicine

Dermatology and Skin DiseasesPsoriasis: Treatment and Pathogenesis

Cited by 158

Persistent somatic symptoms across diseases - from risk factors to modification: scientific framework and overarching protocol of the interdisciplinary SOMACROSS research unit (RU 5211)

Löwe, B., Andresen, V., Van den Bergh, O., Huber, T. B., von dem Knesebeck, O., Lohse, A. W., Nestoriuc, Y., Schneider, G., Schneider, S. W., Schramm, C., et al. (2022) · BMJ Open

Psychosomatic Disorders and Their TreatmentsMusculoskeletal pain and rehabilitation

Cited by 121

Serlopitant reduced pruritus in patients with prurigo nodularis in a phase 2, randomized, placebo-controlled trial

Ständer, S., Kwon, P., Hirman, J., Perlman, A. J., Weisshaar, E., Metz, M., & Luger, T. A. (2019) · Journal of the American Academy of Dermatology

Dermatology and Skin DiseasesUrticaria and Related Conditions

Cited by 118

The pathogenesis of Prurigo nodularis – ‘Super‐Itch’ in exploration

Zeidler, C., & Ständer, S. (2016) · European Journal of Pain

Dermatology and Skin DiseasesMedicine and Dermatology Studies History

Cited by 91

NK-1 Antagonists and Itch

Ständer, S., & Luger, T. A. (2015) · Handbook of Experimental Pharmacology

Dermatology and Skin DiseasesPain Mechanisms and Treatments

Cited by 67

Neurokinin‐1 receptor antagonist tradipitant has mixed effects on itch in atopic dermatitis: results from EPIONE, a randomized clinical trial

Welsh, S. E., Xiao, C., Kaden, A. R., Brzezynski, J. L., Mohrman, M. A., Wang, J., Smieszek, S. P., Przychodzen, B., Ständer, S., Polymeropoulos, C., et al. (2021) · Journal of the European Academy of Dermatology and Venereology

Dermatology and Skin DiseasesContact Dermatitis and Allergies

Cited by 44

Psychosomatic and psychiatric disorders and psychologic factors in pruritus

Stumpf, A., Schneider, G., & Ständer, S. (2018) · Clinics in Dermatology

Dermatology and Skin DiseasesPsychosomatic Disorders and Their Treatments

Cited by 43

The NK1 receptor antagonist serlopitant for treatment of chronic pruritus

Ständer, S., Spellman, M. C., Kwon, P., & Yosipovitch, G. (2019) · Expert Opinion on Investigational Drugs

Dermatology and Skin DiseasesUrticaria and Related Conditions

Cited by 26